With YoY Sales Growth of 0.04402, Should Mediclinic International plc (LSE:MDC) Be on Investor’s Wishlist?

Mediclinic International plc (LSE:MDC) have seen a year over year change of sales growth of 0.04402.  The 4221616 market value company based out of Great Britain is an important player in the Health Care Equipment & Services sector.

While sales growth can be a key driver for a company’s stock performance, there are many other factors to consider as well.  Here we’ll take a look at several other notable indicators.

As any seasoned investor knows, markets can move up or down in the blink of an eye. Investors who attempt to beat the market without creating a plan may find themselves grasping at straws down the line. Building a plan that included the right level of risk may be different for every individual. Managing risk and staying on top of the stock portfolio can help investors ride out the storm when it eventually rolls in. Anybody who manages their own portfolio knows that it can be extremely challenging at times. Finding a consistent process that works when markets become volatile can be a big help to the investor. Controlling emotions and conducting the necessary research can help the investor make the difficult decisions when they crop up.

So how has Mediclinic International plc (LSE:MDC) performed in terms of returns?  The ROIC quality score stands at 27.644886 whilet he actual return on invested capital holds at  0.080236.  Mediclinic International plc’s book to market ratio is at 1.009957 while the book to market mean difference is 0.30832. This indicator tells you how a company is currently valued in terms of Book to Market compared to its average Book to Market over the past 10 years. It’s important to note that BM is the inverse of the Price to book ratio. Thus a high BM ratio means a company is undervalued.

In glancing at some key ratios we note that the Piotroski F-Score is at 4 (1 to 10 scale) and the ERP5 rank is at 4510. The Q.I. Value of Mediclinic International plc (LSE:MDC) currently reads 26.00000 on the Quant scale. The Free Cash Flow score of 0.376450 is also swinging some momentum at investors. The Great Britain based firm is currently valued at 8775.

Some other notable ratios include the Accrual Ratio of -0.328981, the Altman Z score of 2.084903, a Montier C-Score of 1.00000 and a Value Composite rank of 36.


In looking at some Debt ratios, Mediclinic International plc (LSE:MDC) currently has a debt to equity ratio of 0.59008 and a Free Cash Flow to Debt ratio of 0.046931. This ratio gives insight as to how high the firm’s total debt is compared to its free cash flow generated. In terms of Net Debt to EBIT, that ratio stands at 4.73729. This ratio reveals how easily a firm is able to pay interest and capital on its net outstanding debt. The lower the ratio the better as that indicates that the company is able to meet its interest and capital payments. Lastly we’ll take note of the Net Debt to Market Value ratio. Mediclinic International plc’s ND to MV current stands at 0.515428. This ratio is calculated as follows: Net debt (Total debt minus Cash ) / Market value of the company.

It is no secret that most investors have the best of intentions when diving into the equity markets. Making sound, informed decisions can help the investor make the most progress when dealing with the markets. Often times, investors may think they have everything in order, but they still come out on the losing end. Investors may need to figure out ways to keep emotion out of stock picking. Sometimes trading on emotions can lead to poor results. Making hasty decisions and not paying attention to the correct data can lead to poor performing portfolios in the long-term.

Mediclinic International plc (LSE:MDC) are showing an adjusted slope average of the past 125 and 250 days of -28.44420.  The Adjusted Slope 125/250d indicator is equal to the average annualized exponential regression slope, over the past 125 and 250 trading days, multiplied by the coefficient of determination (R2).  The purpose of this calculation is to provide a longer term average adjusted slope value that levels out large share price movements by using the average. This indicator is useful in helping find stocks that have been on a smooth upward trend over the past 6 months to a year.

Drilling down into some additional key near-term indicators we note that the Capex to PPE ratio stands at 0.070752 for Mediclinic International plc (LSE:MDC).  The Capex to PPE ratio shows you how capital intensive a company is. Stocks with an increasing (year over year) ratio may be moving to be more capital intensive and often underperform the market. Higher Capex also often means lower Free Cash Flow (Operating cash flow – Capex) generation and lower dividends as companies don’t have the cash to pay dividends if they are investing more in the business.

Investors may be trying to gauge the current business cycle phase and how that could potentially impact the portfolio. Business cycles can be one way to analyze portfolio performance. Early on in the cycle, profits tend to grow rapidly, sales tend to improve, and activity rebounds. In the middle of a cycle, growth may be peaking, strong credit growth may still be seen, and policy may swing neutral. Toward the later stages, growth may be moderate, earnings may come under pressure, and credit may tighten. Heading into a period of recession, credit may completely dry up, profits may decline sharply, and there may be policy easing. Investors will often have to adjust portfolio holdings that reflect the current state of a business cycle.